Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by RazeKreationson Feb 12, 2022 5:02pm
164 Views
Post# 34423596

RE:RE:RE:RE:MD&A

RE:RE:RE:RE:MD&AThe reduction of covid testing will not adversley effect Microbix. Just opens the door for other testing.And their market is worldwide, not just Canada. They have a very large stable of Qap's that will be in demand and required by many health authorities.
The reason for the government to test less for covid is to allow for testing of other testing was ignored resulting in many people ending up in a worse condition, than if they had been diagnosed early.  Antigen test's only show if you have immunity or have had exposure to a pathogen. There is an especially wide avenue for false negatives in antibody tests, although the particulars depend on which disease and which test are involved. Anybody testing positive with a home test are recommended to get a pcr test to confirm.

tasman99 wrote: It does make sense. My only worry about it is they are expecting a uptick in testing when the governments current position is test less. The only way testing is covered and pushed by the healthcare system is if something is really pathogenic (1+% death rate, 3+% hospitalization).
 
In hospitals they use a different PCR test which is not antigen based to see what the patients carry.
 
I can see a private market opening up for this type of thing though. Home tests to see what you have purchased at stores.
 



<< Previous
Bullboard Posts
Next >>